Advertisement

Topics

Latest "Forest Laboratories, Inc. and Clinical Data, Inc." News Stories

07:56 EST 13th December 2018 | BioPortfolio

Here are the most relevant search results for "Forest Laboratories, Inc. and Clinical Data, Inc." found in our extensive news archives from over 250 global news sources.

More Information about Forest Laboratories, Inc. and Clinical Data, Inc. on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Forest Laboratories, Inc. and Clinical Data, Inc. for you to read. Along with our medical data and news we also list Forest Laboratories, Inc. and Clinical Data, Inc. Clinical Trials, which are updated daily. BioPortfolio also has a large database of Forest Laboratories, Inc. and Clinical Data, Inc. Companies for you to search.

Showing "Forest Laboratories Clinical Data" News Articles 1–25 of 37,000+

Thursday 13th December 2018

Johnson Johnson JNJ Medical Equipment Deals and Alliances Profile [Report Updated: 16102018] Prices from USD $250

SummaryJohnson Johnson JJ researches and develops, and manufactures and sells a range of pharmaceutical products, medical devices and consumer products. The company provides pharmaceuticals for immune diseases, cancer, neurological disorders, infectious, cardiovascular and metabolic diseases; consumer products in baby care, oral care, beauty, overthecounter OTC pharmaceutical, women's health and ...


Psoriasis Global Clinical Trials Review, H1, 2018 [Report Updated: 29062018] Prices from USD $2125

Psoriasis Global Clinical Trials Review, H1, 2018SummaryGlobalData's clinical trial report, Psoriasis Global Clinical Trials Review, H1, 2018" provides an overview of Psoriasis clinical trials scenario. This report provides top line data relating to the clinical trials on Psoriasis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the glob...

United Kingdom Neurovascular Embolization Procedures Outlook to 2025 [Report Updated: 15112018] Prices from USD $2546

United Kingdom Neurovascular Embolization Procedures Outlook to 2025SummaryGlobalData's new report, United Kingdom Neurovascular Embolization Procedures Outlook to 2025, provides key procedures data on the United Kingdom Neurovascular Embolization Procedures. The report provides procedure volumes within market segments Aneurysm Clipping Procedures, Embolization Coiling Procedures, Flow Diversion ...


Italy Neurovascular Embolization Procedures Outlook to 2025 [Report Updated: 15112018] Prices from USD $2546

Italy Neurovascular Embolization Procedures Outlook to 2025SummaryGlobalData's new report, Italy Neurovascular Embolization Procedures Outlook to 2025, provides key procedures data on the Italy Neurovascular Embolization Procedures. The report provides procedure volumes within market segments Aneurysm Clipping Procedures, Embolization Coiling Procedures, Flow Diversion Stent Procedures and Liquid...

$RYTM First Patient Enrolled in Pivotal Ph 3 Clinical Trial Evaluating Setmelanotide in Bardet-Biedl and Alström Syndromes https://globenewswire.com/news-release/2018/12/13/1666510/0/en/Rhythm-Pharmaceuticals-Announces-First-Patient-Enrolled-in-Pivotal-P

$RYTM First Patient Enrolled in Pivotal Ph 3 Clinical Trial Evaluating Setmelanotide in Bardet-Biedl and Alström Syndromes https://globenewswire.com/news-release/2018/12/13/1666510/0/en/Rhythm-Pharmaceuticals-Announces-First-Patient-Enrolled-in-Pivotal-Phase-3-Clinical-Trial-Evaluating-Setmelanotide-in-Bardet-Biedl-and-Alstr%C3%B6m-Syndromes.html …

NeuroRx Presents Phase 2 Efficacy & Safety Data for NRX-101, a Breakthrough Therapy Targeting Suicidal Bipolar Depression

Findings suggest potential for NRX-101 in maintaining remission from Severe Bipolar Depression with Acute Suicidal Ideation following initial stabilization with ketamine NeuroRx, a clinical stage biopharma company focused on the development of Rapid Acting Antidepressants (RAADs) that target the brain’s NMDA receptor, announced results from its Phase...

Newly Published Case Series Demonstrates the Karius Test’s Effectiveness for Monitoring Infections in Stem-Cell Transplant Patients at Risk of Infections

Karius and Clinical Investigators from UCSF Showed that the Karius Test can Quickly and Accurately Detect Infections Earlier than Standard Diagnostics in Immunocompromised Patients REDWOOD CITY, Calif. (PRWEB) December 13, 2018 Karius, Inc., a life sciences company transforming infectious disease diagnostics with genomics, announced today the results of an ongoing clinical study of adult patients...

FileCloud Announces HIPAA Supported File Sharing for Global Healthcare Sector

Health Insurance Portability and Accountability Act (HIPAA) compliant file sharing platform empowers healthcare providers with industry-specific features Hospitals, healthcare agencies, researchers, providers and insurers turn to FileCloud for freedom, flexibility and security around patient data Intern...

Vitamin D Deficiency and Mortality in Maintenance Dialysis

Findings from a new study highlight the need for clinical trials investigating the effects of vitamin D supplementation among patients receiving hemodialysis. Nephrology Dialysis Transplantation

Tetanus Global Clinical Trials Review, H2, 2018 [Report Updated: 31082018] Prices from USD $2125

Tetanus Global Clinical Trials Review, H2, 2018SummaryGlobalData's clinical trial report, Tetanus Global Clinical Trials Review, H2, 2018" provides an overview of Tetanus clinical trials scenario. This report provides top line data relating to the clinical trials on Tetanus. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The r...

University of Queensland Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 27092018] Prices from USD $250

SummaryUniversity Of Queensland UQ is a research institute. The university manages personal, career, welfare and learning issues. It conducts research in the areas of physical sciences, biological sciences, technology, biomedical and clinical health sciences, engineering, chemical sciences and environmental sciences, among others. UQ provides educational courses in the areas of arts, architecture ...

$IMV Presents Updated Data From Phase 1b/2 Combo Clinical Trial in Advanced Ovarian Cancer at #ESMOImmuno18 https://globenewswire.com/news-release/2018/12/13/1666399/0/en/IMV-Inc-Presents-Updated-Positive-Data-From-Phase-1b-2-Combination-Clinical-Trial-in

$IMV Presents Updated Data From Phase 1b/2 Combo Clinical Trial in Advanced Ovarian Cancer at #ESMOImmuno18 https://globenewswire.com/news-release/2018/12/13/1666399/0/en/IMV-Inc-Presents-Updated-Positive-Data-From-Phase-1b-2-Combination-Clinical-Trial-in-Advanced-Ovarian-Cancer-at-2018-ESMO-Immuno-Oncolog

BioVigil Featured in Federal Health & Medicine Publication

Electronic Hand Hygiene Solution Facilitates Positive Client Outcomes ANN ARBOR, Mich. (PRWEB) December 13, 2018 Protecting patients against Healthcare Acquired Infections (HAIs) is always at the forefront of the minds of healthcare leaders. Experts agree that proper hand hygiene is the most effective way to prevent HAIs, and electronic hand hygiene solutions are the most effective way to solve t...

Key opinion leaders’ guide to spinning a disappointing clinical trial result

The onward march of medical science is marred by a great deal of shuffling on the spot, since most wonderful ideas turn out to not work. To maintain a perception of an advancing tide of discovery and...

Ossur Hf : Financial calendar 2019

Announcement no. 71/201813 December 2018 Össur's financial calendar 2019 Interim Report Q4 2018 and Annual Report for 2018     5 February 2019 Annual General Meeting     7 March 2019 Interim Report Q1 2019    

Uncertainty for Pharma and Biotech in 2019 as Sector Stumbles at the End of 2018

Vantage’s Annual Pharma and Biotech Preview explores what’s in store for 2019 The downturn seen in the pharma and biotech sectors in the past few months of 2018 looks set to continue into 2019, with investors in the industry likely to become more cautious. According to Vantage, the independent editorial arm of Evaluate Ltd., the plus side of this c...

Cipla Ltd CIPLA Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 09112018] Prices from USD $250

SummaryCipla Ltd Cipla is a pharmaceutical company, which manufactures and distributes branded medicines, generics and active pharmaceutical ingredients APIs. It offers products for the treatment of various conditions such as cardiovascular and pediatric diseases, dermatological and cosmetological conditions, HIV/AIDS, diabetes, hepatitis, infectious diseases and critical care, malaria, cancer, ne...

Australia Respiratory Device Accessories Market Outlook to 2025 [Report Updated: 12102018] Prices from USD $4246

Australia Respiratory Device Accessories Market Outlook to 2025SummaryGlobalData's new report, Australia Respiratory Device Accessories Market Outlook to 2025, provides key market data on the Australia Respiratory Device Accessories market. The report provides value, in millions of US dollars, volume in units and average prices USD within market segments Aerosol Masks, CardioPulmonary Resuscitati...

China Hydrocephalus Shunts Market Outlook to 2025 [Report Updated: 01112018] Prices from USD $4246

China Hydrocephalus Shunts Market Outlook to 2025SummaryGlobalData's new report, China Hydrocephalus Shunts Market Outlook to 2025, provides key market data on the China Hydrocephalus Shunts market. The report provides value, in millions of US dollars, volume in units and average prices USD within market segments Hydrocephalus Valves and Hydrocephalus Catheters.The report also provides company sh...

Aphthous Ulcers Canker Sores Global Clinical Trials Review, H2, 2018 [Report Updated: 31102018] Prices from USD $2125

Aphthous Ulcers Canker Sores Global Clinical Trials Review, H2, 2018SummaryGlobalData's clinical trial report, Aphthous Ulcers Canker Sores Global Clinical Trials Review, H2, 2018" provides an overview of Aphthous Ulcers Canker Sores clinical trials scenario. This report provides top line data relating to the clinical trials on Aphthous Ulcers Canker Sores. Report includes an overview of trial num...

Aphasia Global Clinical Trials Review, H2, 2018 [Report Updated: 31102018] Prices from USD $2125

Aphasia Global Clinical Trials Review, H2, 2018SummaryGlobalData's clinical trial report, Aphasia Global Clinical Trials Review, H2, 2018" provides an overview of Aphasia clinical trials scenario. This report provides top line data relating to the clinical trials on Aphasia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The r...

Aortic Valve Stenosis Global Clinical Trials Review, H2, 2018 [Report Updated: 31102018] Prices from USD $2125

Aortic Valve Stenosis Global Clinical Trials Review, H2, 2018SummaryGlobalData's clinical trial report, Aortic Valve Stenosis Global Clinical Trials Review, H2, 2018" provides an overview of Aortic Valve Stenosis clinical trials scenario. This report provides top line data relating to the clinical trials on Aortic Valve Stenosis. Report includes an overview of trial numbers and their average enrol...

Aortic Aneurysm Global Clinical Trials Review, H2, 2018 [Report Updated: 31102018] Prices from USD $2125

Aortic Aneurysm Global Clinical Trials Review, H2, 2018SummaryGlobalData's clinical trial report, Aortic Aneurysm Global Clinical Trials Review, H2, 2018" provides an overview of Aortic Aneurysm clinical trials scenario. This report provides top line data relating to the clinical trials on Aortic Aneurysm. Report includes an overview of trial numbers and their average enrollment in top countries c...

Anthrax Global Clinical Trials Review, H2, 2018 [Report Updated: 31102018] Prices from USD $2125

Anthrax Global Clinical Trials Review, H2, 2018SummaryGlobalData's clinical trial report, Anthrax Global Clinical Trials Review, H2, 2018" provides an overview of Anthrax clinical trials scenario. This report provides top line data relating to the clinical trials on Anthrax. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The r...

Angioimmunoblastic TCell Lymphoma AITL/Immunoblastic Lymphadenopathy Global Clinical Trials Review, H2, 2018 [Report Updated: 31102018] Prices from USD $2125

Angioimmunoblastic TCell Lymphoma AITL/Immunoblastic Lymphadenopathy Global Clinical Trials Review, H2, 2018SummaryGlobalData's clinical trial report, Angioimmunoblastic TCell Lymphoma AITL/Immunoblastic Lymphadenopathy Global Clinical Trials Review, H2, 2018" provides an overview of Angioimmunoblastic TCell Lymphoma AITL/Immunoblastic Lymphadenopathy clinical trials scenario. This report provides...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks